Distinct patterns of natural selection in the reverse transcriptase gene of HIV-1 in the presence and absence of antiretroviral therapy (Q44972265)

7 December 2017

title

Distinct patterns of natural selection in the reverse transcriptase gene of HIV-1 in the presence and absence of antiretroviral therapy (English)

1 reference

7 December 2017

2

1 reference

Paolo Marinho de Andrade Zanotto

7 December 2017

series ordinal

3

object named as

Paolo M de A Zanotto

1 reference

7 December 2017

Elcio de S Leal

1

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

325

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

181-191

1 reference

Transmission of zidovudine-resistant HIV-1 through heterosexual contacts

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

HIV-1 drug resistance in newly infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Recombination: Multiply infected spleen cells in HIV patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

MEGA2: molecular evolutionary genetics analysis software

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

HIV-1: gambling on the evolution of drug resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Zidovudine and the natural history of the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

MODELTEST: testing the model of DNA substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

The causes and consequences of HIV evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Production of resistant HIV mutants during antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Linkage disequilibrium test implies a large effective population number for HIV in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Transmission of antiretroviral-drug-resistant HIV-1 variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.04.004

1 reference

7 December 2017

1 reference